A comparative study on proteomics between LNCap and DU145 cells by quantitative detection and SELDI analysis

Abstract

The differences in intracellular and extracellular protein expressions between human prostate cancer lines LNCap and DU145 were examined. The proteins of the two cell lines were extracted and condensed by using protein extraction kits. And the intracellular and extracellular proteins were quantitatively detected on a micro-plate reader by using bicinchoninic acid (BCA) method. The proteins in cell culture fluid were qualitatively assayed by SELDI-TOF-MS. The results showed that the intracellular protein contents of LNCap cells were extremely higher than those of DU145 cells. After serum-free culture, both intracellular and extracellular protein contents of LNCap and DU145 were decreased to some extent. And the intracellular proteins were decreased by 5% in LNCap and by 36% in DU145 respectively, while the extracellular proteins were decreased by 89% in LNCap and 96% in DU145 respectively. SELDI assay revealed that there were 5 marker proteins in LNCap and 6 in DU145. Although both LNCap and DU145 cell lines originated from human prostate cancer, they had some differences in protein expression.

Keywords

prostate cancer / LNCap / DU145 / protein / quantitative and qualitative study / SELDI-TOF-MS

References

[1] KambhampatiS., RayG., SenguptaK., et al.. Growth factors involved in prostate carcinogenesis. Front Biosci, 2005, 1(10): 1355-1367

[2] EngwegenJ. Y., GastM. C., SchellensJ. H., et al.. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci, 2006, 27(5): 251-259

[3] RobozJ.. Mass spectrometry in diagnostic oncoproteomics. Cancer Invest, 2005, 23(5): 465-478

[4] PanY. Z., XiaoX. Y., ZhaoD., et al.. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer. Asian J Androl, 2006, 8(1): 45-51

[5] HellströmM., LexanderH., FranzénB., et al.. Proteomics in prostate cancer research. Anal Quant Cytol Histol, 2007, 29(1): 32-40

[6] SkyttA., ThysellE., StattinP., et al.. SELDI-TOF-MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer. Int J Cancer, 2007, 121(3): 615-620

[7] SemmesO. J., FengZ., AdamB. L., et al.. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reprocibility. Clin Chem, 2005, 51(1): 102-112

[8] KohliM., SiegelE., BhattacharyaS., et al.. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) for deter mining prognosis in advanced stage hormone relapsing prostate cancer. Cancer Biomark, 2006, 2(6): 249-258

[9] FariaP. C., SabaK., NevesA. F., et al.. Transforming growth factor-beta 1 gene poly-morphisms and expression in the blood of prostate cancer patients. Cancer Invest, 2007, 25(8): 726-732

[10] GhoshR., GarciaG. E., CrosbyK., et al.. Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine. Neoplasia, 2007, 9(11): 893-899

[11] LeL., ChiK., TyldesleyS., et al.. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin Chem, 2005, 51(4): 695-707

[12] MalikG., WardM. D., GuptaS. K., et al.. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res, 2005, 11(3): 1073-1085

[13] EngwegenJ. Y., HelgasonH. H., CatsA., et al.. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J Gastroenterol, 2006, 12(10): 1536-1544

[14] LeL., ChiK., TyldesleyS., et al.. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin Chem, 2005, 51(4): 695-707

[15] ParkY., DowningS. R., KimD., et al.. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data. Bioinformatics, 2007, 23(12): 1451-1458